Skip to main content
. Author manuscript; available in PMC: 2019 Nov 14.
Published in final edited form as: Clin Lung Cancer. 2015 Oct 22;17(1):10–7.e1. doi: 10.1016/j.cllc.2015.09.004

Table 3.

Lung Cancer Death by Year Since Randomization

Years Since Randomization Placebo, n (% Per Year) E+P, n (% Per Year) Hazard ratio (95% CI)
1 2 (0.02) 2 (0.02) 0.96 (0.13–6.78)
2 8 (0.10) 4 (0.05) 0.48 (0.14–1.59)
3 3 (0.04) 9 (0.11) 2.89 (0.78–10.66)
4 6 (0.08) 10 (0.12) 1.59 (0.58–4.37)
5 9 (0.11) 11 (0.13) 1.17 (0.48–2.82)
6 7 (0.09) 13 (0.16) 1.78 (0.71–4.45)
7 9 (0.12) 12 (0.15) 1.28 (0.54–3.03)
8 7 (0.09) 19 (0.24) 2.59 (1.09–6.16)
9 8 (0.11) 11 (0.14) 1.31 (0.53–3.27)
10 13 (0.18) 13 (0.17) 0.96 (0.44–2.06)
11 13 (0.18) 9 (0.12) 0.66 (0.28–1.55)
12 15 (0.22) 17 (0.24) 1.08 (0.54–2.16)
13 13 (0.22) 12 (0.19) 0.87 (0.40–1.91)
14+ 19 (0.16) 11 (0.08) 0.53 (0.25–1.12)
Total 132 (0.12%) 153 (0.13%)